What does it mean? Looking beyond group differences in clinical research

An inventory of European data sources for the long-term safety evaluation of methylphenidate

Murray, M. L., Insuk, S., Banaschewski, T., Neubert, A. C., McCarthy, S., Buitelaar, J. K., Coghill, D., Dittmann, R. W., Konrad, K., Panei, P., Rosenthal, E., Sonuga-Barke, E. J. & Wong, I. C. K. Mar-2013 In : European Child & Adolescent Psychiatry.

Research output: Contribution to journal › Article

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Hodgkins, P., Shaw, M., Coghill, D., Hechtman, L. & Coghill, D. 2012 In : European Child & Adolescent Psychiatry. 21, 9, p. 477-492, 16 p.

Research output: Contribution to journal › Scientific review

Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee

Coghill, D. & Seth, S. Feb-2011 In : European Child & Adolescent Psychiatry. 20, 2, p. 75-81, 7 p.

Research output: Contribution to journal › Article

European guidelines on managing adverse effects of medication for ADHD

Graham, J. , Banaschewski, T. , Buitelaar, J. , Coghill, D. , Danckaerts, M. , Dittmann, R. W. , Doepfner, M. , Hamilton, R. , Hollis, C. , Holtmann, M. , Hulpke-Wette, M. , Lecendreux, M. , Rosenthal, E. , Rothenberger, A. , Santosh, P. , Sergeant, J. , Simonoff, E. , Sonuga-Barke, E. , Wong, I. C. K. , Zuddas, A. & 3 others Steinhausen, H. -C., Taylor, E. & European Guidelines Grp Jan-2011 In : European Child & Adolescent Psychiatry. 20, 1, p. 17-37, 21 p.

Research output: Contribution to journal › Article